NCT03162549View on ClinicalTrials.gov

CorEvitas Inflammatory Bowel Disease (IBD) Registry

Enrolling by invitationOBSERVATIONAL

Enrollment

2,287

Participants

Timeline

Start Date

March 27, 2017

Primary Completion Date

December 31, 2100

Study Completion Date

December 31, 2100

Conditions

Inflammatory Bowel Diseases

Trial Locations (1)

02451

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CorEvitas

NETWORK

NCT03162549 - CorEvitas Inflammatory Bowel Disease (IBD) Registry | Biotech Hunter | Biotech Hunter